Advisory Committee on Childhood Lead Poisoning Prevention (ACCLPP), National Center for Environmental Health (NCEH), 38600 [E7-13596]

Download as PDF 38600 Federal Register / Vol. 72, No. 134 / Friday, July 13, 2007 / Notices TOTAL ESTIMATED ANNUALIZED BURDEN HOURS—Continued Number of respondents Respondents Laboratory Test Result Form ................................................................................................. Dated: July 9, 2007. Maryam Daneshvar, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E7–13605 Filed 7–12–07; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Committee on Childhood Lead Poisoning Prevention (ACCLPP), National Center for Environmental Health (NCEH) pwalker on PROD1PC71 with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announce the following meeting of the aforementioned committee: Times and Dates: 8:30 a.m.–5 p.m., September 18, 2007. 8:30 a.m.–12:30 p.m., September 19, 2007. Place: Radisson Plaza Hotel Minneapolis, 35 South 7th Street, Minneapolis, MN 55402, Telephone: (612) 339–4900. Open to the public, limited only by the space available. The meeting room accommodates approximately 75 people. Purpose: The Committee provides advice and guidance to the Secretary; the Assistant Secretary for Health; and the Director, CDC, regarding new scientific knowledge and technological developments and their practical implications for childhood lead poisoning prevention efforts. The Committee also reviews and reports regularly on childhood lead poisoning prevention practices and recommends improvements in national childhood lead poisoning prevention efforts. Matters To Be Discussed: The meeting will include discussion on the potential approaches to strengthen existing strategies to achieve the Healthy People 2010 goal of eliminating Elevated Blood Lead Levels as a Public Health Problem in the United States by 2010, the development of a prevention based research agenda, and the study designs related to adverse effects from Blood Lead Levels (BLLs) < 10 µg/dl; and updates on the school performance and concurrent BLLs. Agenda items are subject to change as priorities dictate. Opportunities will be provided during the meeting for oral comments. Depending on the time available and the number of requests, it may be necessary to limit the time of each presenter. VerDate Aug<31>2005 19:05 Jul 12, 2007 Jkt 211001 Contact Person for More Information: Claudine Johnson, Clerk, Lead Poisoning Prevention Branch, Division of Environmental Emergency Health Services, NCEH, CDC, 4770 Buford Hwy, NE., Mailstop F–40, Atlanta, GA 30341, Telephone (770) 488–3629, Fax (770) 488–3635. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: July 6, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7–13596 Filed 7–12–07; 8:45 am] BILLING CODE 4163–18–P Number of responses per respondent 754 Average burden per response (in hours) 2 10/60 evaluation of research grant applications in response to RFA DP07–707, ‘‘Racial and Ethnic Approaches to Community Health Across the United States (REACH US).’’ For Further Information Contact: Thijuanie Lockhart, Program & Management Analyst, CDC, 4770 Buford Highway, NE., Mail Stop K–30, Atlanta, GA 30341, Telephone (404) 488–5303. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: July 9, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7–13602 Filed 7–12–07; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Racial and Ethnic Approaches to Community Health Across the United States (REACH US), Request for Applications (RFA) DP07– 707 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Public Law 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting of the aforementioned Special Emphasis Panel. Times and Dates: 3 p.m.–8 p.m., July 31, 2007 (Closed), 8 a.m.–5 p.m., August 1, 2007 (Closed), 8 a.m.–5 p.m., August 2, 2007 (Closed), 3 p.m.–8 p.m., August 6, 2007 (Closed), 8 a.m.–5 p.m., August 7, 2007 (Closed), 8 a.m.–5 p.m., August 8, 2007 (Closed), 8 a.m.–5 p.m., August 9, 2007 (Closed). Place: Sheraton Gateway Hotel Atlanta Airport, 1900 Sullivan Road, Atlanta, GA 30337, Telephone (800) 454–6835. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Pub. L. 92–463. Matters To Be Discussed: The meeting will include the review, discussion, and PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Statement of Organization, Functions, and Delegations of Authority Part C (Centers for Disease Control and Prevention) of the Statement of Organization, Functions, and Delegations of Authority of the Department of Health and Human Services (45 FR 67772–67776, dated October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as amended most recently at 72 FR 35491–35492, dated June 28, 2007) is amended to reflect the establishment of the Extramural Research Program Office within the National Center for Chronic Disease Prevention and Health Promotion, Coordinating Center for Health Promotion, Centers for Disease Control and Prevention. Section C–B, Organization and Functions, is hereby amended as follows: After the functional statement for the Program Services Branch (CUC13), Office of the Director (CUC1), National Center for Chronic Disease Prevention and Health Promotion (CUC), insert the following: Extramural Research Program Office (CUC18). The Extramural Research Program Office (ERPO) plans, develops, E:\FR\FM\13JYN1.SGM 13JYN1

Agencies

[Federal Register Volume 72, Number 134 (Friday, July 13, 2007)]
[Notices]
[Page 38600]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-13596]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Childhood Lead Poisoning Prevention 
(ACCLPP), National Center for Environmental Health (NCEH)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announce the following meeting of the aforementioned 
committee:

    Times and Dates:
8:30 a.m.-5 p.m., September 18, 2007.
8:30 a.m.-12:30 p.m., September 19, 2007.

    Place: Radisson Plaza Hotel Minneapolis, 35 South 7th Street, 
Minneapolis, MN 55402, Telephone: (612) 339-4900.
     Open to the public, limited only by the space available. The 
meeting room accommodates approximately 75 people.
    Purpose: The Committee provides advice and guidance to the 
Secretary; the Assistant Secretary for Health; and the Director, 
CDC, regarding new scientific knowledge and technological 
developments and their practical implications for childhood lead 
poisoning prevention efforts. The Committee also reviews and reports 
regularly on childhood lead poisoning prevention practices and 
recommends improvements in national childhood lead poisoning 
prevention efforts.
    Matters To Be Discussed: The meeting will include discussion on 
the potential approaches to strengthen existing strategies to 
achieve the Healthy People 2010 goal of eliminating Elevated Blood 
Lead Levels as a Public Health Problem in the United States by 2010, 
the development of a prevention based research agenda, and the study 
designs related to adverse effects from Blood Lead Levels (BLLs) < 
10 [mu]g/dl; and updates on the school performance and concurrent 
BLLs.
    Agenda items are subject to change as priorities dictate.
    Opportunities will be provided during the meeting for oral 
comments. Depending on the time available and the number of 
requests, it may be necessary to limit the time of each presenter.
    Contact Person for More Information: Claudine Johnson, Clerk, 
Lead Poisoning Prevention Branch, Division of Environmental 
Emergency Health Services, NCEH, CDC, 4770 Buford Hwy, NE., Mailstop 
F-40, Atlanta, GA 30341, Telephone (770) 488-3629, Fax (770) 488-
3635.
    The Director, Management Analysis and Services Office has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: July 6, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. E7-13596 Filed 7-12-07; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.